Wetherby Asset Management Inc Neurocrine Biosciences Inc Transaction History

Wetherby Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $12,824 - $14,032	-98 Reduced 5.49%	1,687 $232,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $3,129 - $3,449	24 Added 1.36%	1,785 $246,000
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $11,879 - $14,869	-112 Reduced 5.98%	1,761 $232,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $176,099 - $219,328	1,873 New	1,873 $210,000
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $196,471 - $233,917	1,841 New	1,841 $219,000
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $171,645 - $228,904	-2,155 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $10,600 - $12,180	-123 Reduced 5.4%	2,155 $207,000
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $1,788 - $2,045	-20 Reduced 0.87%	2,278 $222,000
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $201,235 - $274,381	2,298 New	2,298 $224,000
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $3,041 - $3,791	-35 Closed	0 $0
Q3 2020 Dec 16, 2020	SELL	$96.16 - $135.15 $204,724 - $287,734	-2,129 Reduced 98.38%	35 $3,000
Q3 2020 Dec 16, 2020	SELL	$96.16 - $135.15 $3,365 - $4,730	-35 Reduced 1.59%	2,164 $208,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $35,098 - $49,329	365 Added 19.9%	2,199 $211,000
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $156,055 - $239,080	1,834 New	1,834 $223,000

629

94.2M

692K

406K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.